Semaglutide (10 mg Vial)

Semaglutide (10 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Semaglutide (10 mg Vial)

Synonyms/Alias: Semaglutide

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Semaglutide (10 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water β†’ ~ 3.33 mg/mL concentration.

Weekly dose range: 250–2400 mcg (0.25–2.4 mg) once weekly (gradual escalation protocol).

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL β‰ˆ 33.3 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) and use within 28 days.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a proper sharps container [11]. Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and avoid lipohypertrophy [10]. Inject slowly and steadily; wait a few seconds before withdrawing the needle to ensure complete delivery. Administer on the same day each week for consistency; if a dose is missed, take it as soon as possible within 5 days of the missed dose [4]. GLP-1 receptor agonists may cause gastrointestinal side effects (nausea, v

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–4
Weekly Dose: 250 mcg (0.25 mg) | Units (per injection) (mL): 7.5 units (0.075 mL)
Weeks 5–8
Weekly Dose: 500 mcg (0.5 mg) | Units (per injection) (mL): 15 units (0.15 mL)
Weeks 9–12
Weekly Dose: 1000 mcg (1.0 mg) | Units (per injection) (mL): 30 units (0.30 mL)
Weeks 13–16
Weekly Dose: 1700 mcg (1.7 mg) | Units (per injection) (mL): 51 units (0.51 mL)
Weeks 17+ (Maintenance)
Weekly Dose: 2400 mcg (2.4 mg) | Units (per injection) (mL): 72 units (0.72 mL)
Long-term Storage Conditions
Lyophilized: freeze at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) and use within 28 days.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Semaglutide, 10 mg each): 8 weeks β‰ˆ 1 vial (3 mg total used)

12 weeks β‰ˆ 1 vial (7 mg total used)

16 weeks β‰ˆ 2 vials (13.8 mg total used)

20 weeks β‰ˆ 3 vials (23.4 mg total used with maintenance dosing)

Insulin Syringes (U-100): Per week: 1 syringe

8 weeks: 8 syringes

12 weeks: 12 syringes

16 weeks: 16 syringes

20 weeks: 20 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (1 vial): 3 mL β†’ 1 Γ— 10 mL bottle

12 weeks (1 vial): 3 mL β†’ 1 Γ— 10 mL bottle

16 weeks (2 vials): 6 mL β†’ 1 Γ— 10 mL bottle

20 weeks (3 vials): 9 mL β†’ 1 Γ— 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs

8 weeks: 16 swabs

12 weeks: 24 swabs

16 weeks: 32 swabs

20 weeks: 40 swabs β†’ recommend 1 Γ— 100-count box

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services